Navigation Links
New UNC Center for Diabetes seeks to reduce health disparities
Date:9/26/2011

Chapel Hill, NC (September 26, 2011) -- The University of North Carolina at Chapel Hill has received a $3 million, 5-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases to establish the UNC Center for Diabetes Translation Research to Reduce Health Disparities (CDTR). Its mission is to reduce diabetes-related disparities among poor and underserved populations by providing resources and support to foster translational research in North Carolina and beyond. The center's research will examine and compare different techniques for bringing effective preventive and therapeutic interventions into practice.

Currently, 1 in 9 adults in the U.S. (about 264 million) has Type 2 diabetes. If trends continue, projections suggest that 1 in 3 people may have the condition by 2050. Diabetes-related annual costs are currently $174 billion and may increase to $336 billion by 2034. Poor, minority and rural populations with limited access to health care suffer disproportionately. Especially in North Carolina, African-American, Hispanic and Native American populations have a higher rate of diabetes and related complications.

One of seven such centers in the nation established by the National Institutes of Health, the UNC CDTR will share resources and encourage collaboration on research that moves further along the translational continuum -- getting improved treatments applied in communities and validating that they make a difference. This critical step adds to the wealth of diabetes care and research already at UNC by over 200 researchers working on $350 million (since 2000) in funded research.

The UNC CDTR will leverage existing resources at the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, home of UNC's NIH Clinical and Translational Science Awards (CTSA). NC TraCS is part of a national consortium whose mission is to accelerate movement of research discoveries into patient therapies and communit
'/>"/>

Contact: Michelle A. Maclay
Michelle_Maclay@med.unc.edu
919-843-5365
University of North Carolina School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Non-communicable diseases at the center of UN discussions
2. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
3. John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
4. National Cancer Institute establishes $11.3 million center at Case Western Reserve
5. University Hospitals Case Medical Center awarded 2011 fellowship awards for pain medicine, epilepsy
6. Moffitt Cancer Center researchers use new tool to counter multiple myeloma drug resistance
7. Schwartz Center proposes agenda to promote compassionate care
8. World Trade Center-exposed NYC firefighters face increased cancer risk
9. As Venus Williams Bows Out of U.S. Open, Little-Known Disease Takes Center Court
10. Specialized Stroke Centers Deliver on the Weekends
11. Fred Hutchinson Cancer Research Center to co-lead 1 of 5 NCI-funded proteomics research centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Christopher Asandra, M.D., Founder and Chief Medical Officer of ... recent decision to issue a warning on testosterone ... are not supported by science, and that the warning ... “The FDA appears to have developed a case of ... “There is not nearly enough evidence to support the ...
(Date:3/4/2015)... TROY Healthcare Solutions will be introducing TROY ... level of security for prescriptions, in Houston, Texas on ... Center located at 6633 Travis Street from 7 AM ... TROY Healthcare Solutions will host a continental breakfast. Starting ... presentations each hour to introduce attendees to TROY Secure ...
(Date:3/4/2015)... 04, 2015 Cook For Your Life ... teaches healthy cooking to people touched by cancer, is ... The program, run by founder Ann Ogden, will be ... Management. The unique partnership will expand the program from ... CFYL in 2007. After going through her own cancer ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Smokers across ... marketing campaign called 'We Love Smokers' from Aqua-Tine, the ... tobacco. , "It’s important to establish a clear ... to it. Our idea, 'We Love Smokers' elevates the ... of view. We created a bold tone of voice ...
(Date:3/4/2015)... Blake’s All Natural Foods , ... attend this year’s Natural Products Expo West in Anaheim, ... this new line, Blake’s, who has the top four ... its commitment to creating high-quality dishes that are easily ... the natural channel, Blake’s understands what educated consumers are ...
Breaking Medicine News(10 mins):Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3
... some students experience while taking their exams may also affect ... allergy// , scientists say. ,Mats Lekander and other ... medical exam affects stress hormone levels, the immune system and ... ,The extensive tests were conducted on two occasions - first ...
... death toll from the ‘Typhoon Saomai’ has risen to 330. ... had increased// after 6 more bodies were discovered in the ... bodies were fished out from the sea, off the Shacheng ... 186. ,Cai Meisheng, vice mayor of Fuding, said ...
... eyesight, but according to a recent research, yellow and green vegetables ... be good for the eyesight. ,The diets of 1,700 American ... researchers at the University of Wisconsin to observe the affect of ... carried out by asking each woman what was her regular diet ...
... that getting married may benefit depressed people more than it ... beneficial to the general well being of a person, but ... health aspect of tying the knot. ,“Our findings question ... for all individuals,” observed co-author Adrianne Frech, a doctoral student ...
... child attending the Craigneuk Nursery Centre in Wishaw is recovering at ... O157 infection. ,The Craigneuk Nursery Centre cares for ... ,A NHS Lanarkshire, spokesman who refused to reveal ... children had been contacted as a precaution. ,A ...
... has touched the 25 year mark and this year ... With increasing// access to lifesaving treatments last year even ... reported declining HIV infection rates. However Bill Gates addressing ... that current trends don’t bode well for the future ...
Cached Medicine News:Health News:Yellow and green vegetables for better eyesight 2Health News:Need for Change in Social Norms to Prevent Spread of HIV 2Health News:Need for Change in Social Norms to Prevent Spread of HIV 3
(Date:3/4/2015)... Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), ... today announced its financial results for the fourth quarter ... 2014 Financial Highlights , Total sales in ... 36.8% excluding the impact of foreign currency exchange rate ... same quarter of 2013. , Gross profit increased ...
(Date:3/4/2015)... Mass., March 4, 2015 GSI Group Inc. ... "GSI"),  a global leader and supplier of precision photonics ... equipment and advanced industrial technology markets, today reported financial ... Unless otherwise noted, all financial results in this press ... Fourth QuarterDuring the fourth quarter of 2014, GSI ...
(Date:3/4/2015)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ... the research, development and commercialization of prescription ophthalmic ... quarter and year ended December 31, 2014. ... for Alimera Sciences, most notably having received U.S. ... treatment of diabetic macular edema," said Dan Myers, ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15
... of Disease Activity as Measured,by MRI and Relapse ... May 1, 2007 -- Genentech, Inc.,(NYSE: DNA) ... from a Phase II clinical study of Rituxan®,(rituximab) in ... the American Academy of Neurology,annual meeting held in Boston. ...
... BOSTON--(BUSINESS WIRE)--May 1, 2007 - Significantly more patients,treated ... percent or,more compared with placebo, according to study ... annual meeting.,Clinically, this outcome would equate to a ... to moderate pain., Fibromyalgia is one of the ...
Cached Medicine Technology:Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6Lyrica Significantly Reduced Pain and Helped Patients Manage the,Symptoms of Fibromyalgia, Data Show 2Lyrica Significantly Reduced Pain and Helped Patients Manage the,Symptoms of Fibromyalgia, Data Show 3
Straight shafts with 4 mm platform. Wide serrated handle with dull finish. Platform straight....
Regular tip. 1 mm x 13 mm. Serrated. Insulated....
Straight shafts with fine tips and dull finish. Insulated stop with tip gap set at 0.3 mm. Smooth handle....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Medicine Products: